The Australian Pesticides and Veterinary Medicines Authority (APVMA) is considering an application for the registration of a new veterinary chemical product Nobivac puppy DP PLUS live vaccine, containing approved actives CANINE DISTEMPER VIRUS (CDV), Strain Onderstepoort (LIVE) (APVMA No. 93570) and LIVE RECOMBINANT CANINE PARVOVIRUS 2c Strain 630a (APVMA No. 93572).
We invite relevant written comment from 22 September to 22 October 2026 on whether registration of the new veterinary product should be granted.
The APVMA is able to consider comments relating to the legislative grounds, including:
- Chemistry and manufacture
- Human health
- Environmental safety
- Target animal safety and efficacy
For more information see page 76 in the APVMA Gazette No 19, Tuesday 22 September 2026.
Please lodge your submission with a public submission coversheet. The coversheet provides options for how your submission will be published.
Please note that submissions will be published on the APVMA’s website unless you have asked for the submission to remain confidential. Note that all APVMA documents are subject to the access provisions of the Freedom of Information Act 1982 and may be required to be released under that Act should a request for access be made.
Please send your written submission by email or post to:
Case Management
Australian Pesticides and Veterinary Medicines Authority
GPO Box 574
Canberra ACT 2601, Australia
Email: casemanagement@apvma.gov.au